Current Status

Not Enrolled

Price

NZ$99.00

Get Started

FAQs - Prescribing Guidance and Standards for Healthcare Professionals | New Zealand CPD Course

Prescribing Guidance and Standards for Healthcare Professionals

Course Description

Prescribing is one of the most complex and high-risk activities undertaken by healthcare professionals. In New Zealand, prescribing concerns are a leading cause of patient harm, complaints, employer investigation, and regulatory action. Issues frequently arise not from deliberate misconduct, but from poor prescribing decisions, inadequate monitoring, documentation failures, boundary issues, or lack of insight after errors occur.

This course provides a comprehensive, practical, and regulator-aligned overview of safe prescribing standards in New Zealand healthcare practice. It focuses on professional expectations, clinical judgement, patient-centred decision-making, documentation, monitoring, and responding appropriately to prescribing errors or concerns. Particular emphasis is placed on how prescribing behaviour is assessed by employers and regulators, and how insight, reflection, and remediation influence outcomes.

The course is suitable for all healthcare professionals involved in prescribing, supplying, administering, or influencing medicines in New Zealand, including doctors, nurse practitioners, dentists, pharmacists, and other authorised prescribers regulated under the HPCA framework. It is especially valuable for professionals facing audits, complaints, investigations, or prescribing-related fitness-to-practise concerns.

Frequently Asked Questions

This course provides a comprehensive, practical, and regulator-aligned overview of safe prescribing standards in New Zealand healthcare practice. It focuses on professional expectations, clinical judgement, patient-centred decision-making, documentation, monitoring, and responding appropriately to prescribing errors or concerns.
Prescribing is one of the most complex and high-risk activities undertaken by healthcare professionals. In New Zealand, prescribing concerns are a leading cause of patient harm, complaints, employer investigation, and regulatory action, often arising from poor decisions, inadequate monitoring, or documentation failures.
The course is suitable for all healthcare professionals involved in prescribing, supplying, administering, or influencing medicines in New Zealand, including doctors, nurse practitioners, dentists, pharmacists, and other authorised prescribers regulated under the HPCA framework.
It is especially valuable for professionals facing audits, complaints, investigations, or prescribing-related fitness-to-practise concerns who need to demonstrate safe prescribing standards and professional accountability.
The course focuses on professional expectations, clinical judgement, patient-centred decision-making, documentation, monitoring, and responding to prescribing errors. It provides practical, regulator-aligned guidance for everyday prescribing practice.
Particular emphasis is placed on how prescribing behaviour is assessed by employers and regulators, and how insight, reflection, and remediation influence outcomes when prescribing concerns are identified.
Issues frequently arise not from deliberate misconduct, but from poor prescribing decisions, inadequate monitoring, documentation failures, boundary issues, or lack of insight after errors occur. The course helps professionals recognise and address these risk factors.
Yes, patient-centred decision-making is a key focus alongside clinical judgement, documentation, monitoring, and responding to prescribing errors or concerns in New Zealand healthcare practice.
Yes, the course explains how insight, reflection, and remediation influence outcomes when prescribing concerns are identified. It provides practical guidance on demonstrating safe prescribing practice and professional growth to regulators.
Yes, monitoring is a key area covered alongside professional expectations, clinical judgement, patient-centred decision-making, documentation, and responding to prescribing errors or concerns.

Course Content

Course Objectives
Course Objectives
Section 1: Core Principles of Safe and Ethical Prescribing
1.1 Prescribing as a High-Risk Professional Activity
1.2 Prescribing as Professional Judgement, Not a Technical Task
1.3 The Relationship Between Prescribing and Patient Trust
1.4 Ethical Principles Underpinning Safe Prescribing
1.5 Prescribing Within a Wider Medicines Management System
1.6 Common System and Human Factors Affecting Prescribing
1.7 Prescribing and Professional Accountability
1.8 Regulatory Expectations in New Zealand
1.9 Why Prescribing Concerns Escalate Quickly
1.10 The Purpose of This Course
1.11 Reflective Quiz
Section 2: Prescribing Within Scope, Competence, and Authority
2.1 What “Scope of Practice” Means in Prescribing
2.2 Scope Is Profession-Specific and Role-Specific
2.3 Legal Authority Versus Professional Competence
2.4 Recognising Personal Limits in Prescribing
2.5 Seeking Advice, Supervision, and Referral
2.6 Prescribing in New, Expanded, or Transitional Roles
2.7 Prescribing Outside Scope as a Regulatory Concern
2.8 Shared-Care Arrangements and Prescribing Responsibility
2.9 Prescribing Under Pressure or Expectation
2.10 Documenting Scope and Competence Decisions
2.11 Regulatory Expectations in New Zealand
2.12 Reflective Quiz
Section 3: Patient-Centred Prescribing and Shared Decision-Making
3.1 What Patient-Centred Prescribing Means in Practice
3.2 Shared Decision-Making as a Professional Standard
3.3 Explaining Risks, Benefits, and Uncertainty
3.4 Managing Patient Expectations and Requests for Medicines
3.5 Prescribing When Patients Decline or Are Ambivalent
3.6 Vulnerable Patients and Prescribing Decisions
3.7 Cultural Safety and Prescribing in New Zealand
3.8 Adherence, Monitoring, and Follow-Up
3.9 Documentation of Shared Decision-Making
3.10 Regulatory Perspective on Patient-Centred Prescribing
3.11 Common Pitfalls in Patient-Centred Prescribing
3.12 Reflective Quiz
Section 4: High-Risk Medicines and Controlled Drugs
4.1 Why Some Medicines Carry Higher Prescribing Risk
4.2 What Is Meant by “High-Risk Medicines”
4.3 Controlled Drugs and Regulatory Scrutiny
4.4 Assessing Indication and Alternatives
4.5 Managing Risk of Dependence, Misuse, and Diversion
4.6 Monitoring, Review, and Deprescribing
4.7 Documentation of High-Risk Prescribing Decisions
4.8 Prescribing Under Pressure or Expectation
4.9 Shared-Care and Specialist-Initiated Prescriptions
4.10 Regulatory Perspective in New Zealand
4.11 Common Pitfalls in High-Risk Prescribing
4.12 Reflective Quiz
Section 5: Self-Prescribing and Prescribing for Family, Friends, and Colleagues
5.1 Why Self-Prescribing and Informal Prescribing Are High-Risk
5.2 Loss of Objectivity and Professional Distance
5.3 Absence of Proper Clinical Assessment
5.4 Documentation and Monitoring Failures
5.5 Prescribing for Family Members
5.6 Prescribing for Friends, Colleagues, or Staff
5.7 Emergency Situations: The Limited Exception
5.8 Controlled Drugs and High-Risk Medicines
5.9 Regulatory Expectations in New Zealand
5.10 How Regulators Assess These Cases
5.11 Professional Alternatives to Informal Prescribing
5.12 Learning From Cases Involving Informal Prescribing
5.13 Reflective Quiz
Section 6: Documentation, Monitoring, and Review of Prescriptions
6.1 Why Documentation Is Central to Safe Prescribing
6.2 What Good Prescribing Documentation Should Include
6.3 Documenting High-Risk Prescribing Decisions
6.4 Repeat Prescribing and Ongoing Responsibility
6.5 Monitoring After Prescribing
6.6 Review, Deprescribing, and Stopping Medicines
6.7 Shared-Care Prescribing and Monitoring Responsibilities
6.8 Documentation of Advice and Safety-Netting
6.9 Electronic Prescribing Systems and Pitfalls
6.10 Regulatory Expectations in New Zealand
6.11 Common Documentation and Monitoring Failures
6.12 Reflective Quiz
Section 7: Prescribing Errors, Near Misses, and Adverse Events
7.1 Understanding Prescribing Errors in Context
7.2 Near Misses as Critical Learning Opportunities
7.3 Adverse Drug Events and Prescribing Responsibility
7.4 Common Contributing Factors to Prescribing Errors
7.5 Responding Immediately When an Error Is Identified
7.6 Duty of Candour and Open Communication
7.7 Reporting, Learning, and System Improvement
7.8 Prescribing Errors and Professional Accountability
7.9 When Errors Escalate to Complaints or Investigations
7.10 Regulatory Perspective in New Zealand
7.11 Common Pitfalls After Prescribing Errors
7.12 Reflective Quiz
Section 8: Prescribing-Related Complaints, Audits, and Investigations
8.1 Why Prescribing Concerns Frequently Lead to Complaints
8.3 Common Triggers for Prescribing Audits
8.4 How Investigators Assess Prescribing Practice
8.5 Documentation as Central Evidence
8.6 Professional Behaviour During Complaints and Investigations
8.7 Candour, Apology, and Communication
8.8 Patterns, Repetition, and Escalation
8.9 Regulatory Perspective in New Zealand
8.10 Using Audits and Investigations as Learning Opportunities
8.11 Avoiding Common Mistakes During Investigations
8.12 Reflective Quiz
Section 9: Regulatory Expectations, Insight, and Remediation After Prescribing Concerns
9.1 Why Prescribing Concerns Are Assessed as Trust Issues
9.2 Fitness to Practise: A Forward-Looking Assessment
9.3 How Regulators Assess Prescribing Behaviour
9.4 Insight as the Cornerstone of Regulatory Reassurance
9.5 Honesty and Candour After Prescribing Errors
9.6 What Meaningful Remediation Looks Like in Prescribing Cases
9.7 Behaviour Change: The Most Persuasive Evidence
9.8 Supervision, Mentoring, and Ongoing Support
9.9 Timing and Proactivity in Remediation
9.10 When Regulatory Trust Is Considered Restored
9.11 Reflective Quiz
Section 10: Conclusion and Key Takeaways
Conclusion and Key Takeaways
Post-Course Assessment
Scroll to Top